Pfizer Says Discussions for Expedited Approval of COVID-19 Vaccine on With Centre
The vaccine has not been registered in India even though the application was filed months ago, the Pfizer-BioNTech CEO recently claimed.
Vials labelled COVID-19 Coronavirus Vaccine and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. Photo: Reuters/Dado Ruvic
Health3 hours ago
New Delhi: Global pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company’s Chairman and CEO Albert Bourla said on Monday.
Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.
Synopsis
Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.
Pfizer in talks with Indian govt to allow use of its Covid vaccine
Global Pharma major
Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company s Chairman and CEO Albert Bourla said on Monday.
Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.
Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company s Chairman and CEO Albert Bourla said on Monday. Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India. Pfizer is aware that access to vaccines is critical to ending this pandemic. Unfortunately, our vaccine is not registered in India although our application was submitted months ago. We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country, Bourla said in a mail sent to Pfizer India employees that he has shared on his LinkedIn post.
Pfizer seeks expedited nod for COVID-19 vaccine in India, donates drugs worth USD 70 mn
158
NEW DELHI, May 3, 2021 (BSS/PTI) – Pfizer is in discussions with the Indian government for an expedited approval pathway to make Pfizer-BioNTech vaccine available in the country, its chief Albert Bourla said on Monday, while stating that the firm is donating medicines worth USD 70 million (over Rs 510 crore) for treatment of COVID-19 patients in India.
“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” he said in a mail sent to Pfizer India employees that he posted on linked.in.